128 related articles for article (PubMed ID: 3099459)
1. Monoclonal antibodies recognizing lipid-laden cells and extracellular regions with lipid-deposits in atherosclerotic aorta.
Kimura J; Nakagami K; Amanuma K; Ohkuma S; Yoshida Y; Takano T
Virchows Arch A Pathol Anat Histopathol; 1986; 410(2):159-64. PubMed ID: 3099459
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of a cDNA clone for the antigen.
Sato R; Komine Y; Imanaka T; Takano T
J Biol Chem; 1990 Dec; 265(34):21232-6. PubMed ID: 1701177
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen.
Nakagami K; Shimazaki O; Sato R; Komine Y; Ohkuma S; Takano T
Am J Pathol; 1989 Jul; 135(1):93-100. PubMed ID: 2476036
[TBL] [Abstract][Full Text] [Related]
4. Characterization of vitronectins in atherosclerotic lesions.
Mori M; Iwasaki K; Sato R; Komine Y; Itabe H; Imanaka T; Takano T
J Atheroscler Thromb; 1996; 3(1):25-31. PubMed ID: 9225236
[TBL] [Abstract][Full Text] [Related]
5. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells.
Melián A; Geng YJ; Sukhova GK; Libby P; Porcelli SA
Am J Pathol; 1999 Sep; 155(3):775-86. PubMed ID: 10487835
[TBL] [Abstract][Full Text] [Related]
6. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta of WHHL rabbits.
Amanuma K; Kanaseki T; Ikeuchi Y; Ohkuma S; Takano T
Virchows Arch A Pathol Anat Histopathol; 1986; 410(3):231-8. PubMed ID: 3099465
[TBL] [Abstract][Full Text] [Related]
7. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.
Galis ZS; Sukhova GK; Kranzhöfer R; Clark S; Libby P
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):402-6. PubMed ID: 7831299
[TBL] [Abstract][Full Text] [Related]
8. Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies.
Klurfeld DM
Arch Pathol Lab Med; 1985 May; 109(5):445-9. PubMed ID: 2580504
[TBL] [Abstract][Full Text] [Related]
9. Detection of atherosclerotic plaque with two monoclonal antibodies. 2P1A2 monoclonal antibody is specific for smooth muscle cells in atherosclerotic plaque.
Lamaziere JM; Desmouliere A; Pascal M; Larrue J
Atherosclerosis; 1988 Nov; 74(1-2):115-26. PubMed ID: 3063271
[TBL] [Abstract][Full Text] [Related]
10. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
Spieker-Polet H; Sethupathi P; Yam PC; Knight KL
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9348-52. PubMed ID: 7568130
[TBL] [Abstract][Full Text] [Related]
11. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis.
Aliev G; Burnstock G
Histol Histopathol; 1998 Jul; 13(3):797-817. PubMed ID: 9690137
[TBL] [Abstract][Full Text] [Related]
12. Expression of the LXRalpha protein in human atherosclerotic lesions.
Watanabe Y; Jiang S; Takabe W; Ohashi R; Tanaka T; Uchiyama Y; Katsumi K; Iwanari H; Noguchi N; Naito M; Hamakubo T; Kodama T
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):622-7. PubMed ID: 15625283
[TBL] [Abstract][Full Text] [Related]
13. [Molecular pathology in atherosclerosis: the mechanism by which cholesteryl ester accumulates in atheromatous aorta].
Takano T; Itabe H; Mori M; Kimura J; Nakagami K; Sato R; Hashita R; Yagyu Y; Mineo C; Amanuma K; Imanaka T; Higashi Y; Fujimoto Y; Fujita E
Yakugaku Zasshi; 2008 Oct; 128(10):1383-401. PubMed ID: 18827461
[TBL] [Abstract][Full Text] [Related]
14. Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. A cytochemical and ultrastructural study.
Lupu F; Danaricu I; Simionescu N
Atherosclerosis; 1987 Oct; 67(2-3):127-42. PubMed ID: 2445362
[TBL] [Abstract][Full Text] [Related]
15. Secretory group II phospholipase A2 in human atherosclerotic plaques.
Menschikowski M; Kasper M; Lattke P; Schiering A; Schiefer S; Stockinger H; Jaross W
Atherosclerosis; 1995 Dec; 118(2):173-81. PubMed ID: 8770312
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibodies against recombinant extracellular domain of CD99.
Thangaretnam KP; Paramasivam OR; Ramanathan P; Gopisetty G; Rajkumar T
Hum Antibodies; 2019; 27(1):69-83. PubMed ID: 30282350
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
Boyd HC; Gown AM; Wolfbauer G; Chait A
Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
[TBL] [Abstract][Full Text] [Related]
19. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.
Nakata A; Nakagawa Y; Nishida M; Nozaki S; Miyagawa J; Nakagawa T; Tamura R; Matsumoto K; Kameda-Takemura K; Yamashita S; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1333-9. PubMed ID: 10323787
[TBL] [Abstract][Full Text] [Related]
20. Monocytic origin of foam cells in human atherosclerotic plaques.
Aqel NM; Ball RY; Waldmann H; Mitchinson MJ
Atherosclerosis; 1984 Dec; 53(3):265-71. PubMed ID: 6397199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
